Výsledky vyhledávání - Nobuya Ishii
- Zobrazuji výsledky 1 - 10 z 10
-
1
-
2
-
3
CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant Autor Hiroshi Sakamoto, Toshiyuki Tsukaguchi, Sayuri Hiroshima, Tatsushi Kodama, Takamitsu Kobayashi, Takaaki A. Fukami, Nobuhiro Oikawa, Takuo Tsukuda, Nobuya Ishii, Yuko Aoki
Vydáno 2011Artigo -
4
The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor Autor Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, Takehito Isobe, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii
Vydáno 2014Artigo -
5
The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic <i>PIK3CA</i> Mutations Autor Hiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura, Toshihiko Fujii, Kiyoaki Sakata, Yukako Tachibana, Jun Ohwada, Hirosato Ebiike, Shino Kuramoto, Keiichi Morita, Yasushi Yoshimura, Toshikazu Yamazaki, Nobuya Ishii, Osamu Kondoh, Yuko Aoki
Vydáno 2011Artigo -
6
Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors Autor Piro Lito, Anna Saborowski, Jingyin Yue, Martha Solomon, Eric W. Joseph, Sunyana Gadal, Michael Saborowski, Edward R. Kastenhuber, Christof Fellmann, Kazuhiro Ohara, Kenji Morikami, Takaaki Miura, Christine Lukacs, Nobuya Ishii, Scott W. Lowe, Neal Rosen
Vydáno 2014Artigo -
7
YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification Autor Natsuki Hamanaka, Yoshito Nakanishi, Takakazu Mizuno, Kana Horiguchi-Takei, Nukinori Akiyama, Hiromi Tanimura, Masami Hasegawa, Yasuko Satoh, Yukako Tachibana, Toshihiko Fujii, Kiyoaki Sakata, Kiyomoto Ogasawara, Hirosato Ebiike, Hiroshi Koyano, Haruhiko Sato, Nobuya Ishii, Toshiyuki Mio
Vydáno 2019Carta -
8
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity Autor Nobuya Ishii, Naoki Harada, Eric W. Joseph, Kazuhiro Ohara, Takaaki Miura, Hiroshi Sakamoto, Yutaka Matsuda, Yasushi Tomii, Yukako Tachibana-Kondo, Hitoshi Iikura, Toshihiro Aoki, Nobuo Shimma, Mikio Arisawa, Yoshihiro Sowa, Poulikos I. Poulikakos, Neal Rosen, Yuko Aoki, Toshiyuki Sakai
Vydáno 2013Artigo -
9
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine Autor James Nagarajah, Mina Le, Jeffrey A. Knauf, Giuseppe Ferrandino, Cristina Montero‐Conde, Nagavarakishore Pillarsetty, Alexander Bolaender, Christopher Irwin, Gnana P. Krishnamoorthy, Mahesh Saqcena, Steven M. Larson, Alan L. Ho, Venkatraman Seshan, Nobuya Ishii, Nancy Carrasco, Neal Rosen, Wolfgang Weber, James A. Fagin
Vydáno 2016Artigo -
10
A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring <i>FGFR</i> Gene Alterati... Autor Martin H. Voss, Cinta Hierro, Rebecca S. Heist, James M. Cleary, Funda Meric‐Bernstam, Josep Tabernero, Filip Janků, Leena Gandhi, A. John Iafrate, Darrell R. Borger, Nobuya Ishii, Youyou Hu, Yulia Kirpicheva, Valerie Nicolas‐Métral, Anna Pokorska-Bocci, Anne Vaslin Chessex, Claudio Zanna, Keith T. Flaherty, José Baselga
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Cancer research
Biology
Biochemistry
Cancer
Cell biology
Medicine
Chemistry
Gene
Internal medicine
Kinase
MAPK/ERK pathway
Mutant
Signal transduction
Genetics
MEK inhibitor
Phosphorylation
Cell culture
Fusion gene
Mutation
Receptor
ALK inhibitor
Adverse effect
Allosteric regulation
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Bioaccumulation
Breast cancer
Calcium
Carcinogenesis
Cell cycle